Furthermore, IL‐17A and Th17 cells have been implicated in the progression of non‐alcoholic steatohepatitis (NASH) to HCC, highlighting their role in tumor angiogenesis and inflammation‐driven carcinogenesis [23]. This evidence concerns the gene IL17A and hepatocellular carcinoma.